Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
Article Abstract:
Lovastatin can lower the risk of heart attack in people with high blood cholesterol, high C-reactive protein levels, or both. C-reactive protein is a marker of inflammation, and could be used to detect the early stages of heart disease in people who have no symptoms.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
C-reactive proteins levels and outcomes after Statin therapy
Article Abstract:
Patients who have low C-reactive protein (CRP) levels after Statin therapy have better clinical outcomes than those with higher CRP levels, regardless of the resultant level of low-density lipoprotein (LDL) cholesterol. Strategies of lower cardiovascular risk with Statins are listed.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS
Article Abstract:
Lovastatin appears to lower the risk of heart attack, angina and the need for revascularization procedures in people without heart disease but with low levels of high-density lipoprotein (HDL) cholesterol. This type of cholesterol protects against heart disease. Researchers randomly assigned 5,608 men and 997 women to take lovastatin or placebo every day in addition to a low-fat diet. After an average follow-up of five years, lovastatin reduced the risk of heart attack, angina and other cardiovascular events by 25% to 40%. The need for revascularization procedures such as angioplasty was also reduced.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes
- Abstracts: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
- Abstracts: Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial
- Abstracts: Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial
- Abstracts: Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: Results of AIDS clinical trials group 5108 study